Literature DB >> 16189126

Interaction of the MexA and MexB components of the MexAB-OprM multidrug efflux system of Pseudomonas aeruginosa: identification of MexA extragenic suppressors of a T578I mutation in MexB.

Dominic Nehme1, Keith Poole.   

Abstract

A T578I mutation in MexB compromised the protein's contribution to antimicrobial resistance and negatively impacted its interaction with MexA. Mutations causing single amino acid changes in the C-terminal domain of MexA (R221H, L245F, E254K, and V259I) suppressed the antimicrobial susceptibility of a MexB(T578I)-expressing Pseudomonas aeruginosa strain and restored a MexA interaction with MexB(T578I). These data confirm the importance of the MexA C-terminal region in MexB binding and the likely significance of the region surrounding T587I of MexB in MexA interaction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16189126      PMCID: PMC1251543          DOI: 10.1128/AAC.49.10.4375-4378.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment.

Authors:  Robert E. W. Hancock; David P. Speert
Journal:  Drug Resist Updat       Date:  2000-08       Impact factor: 18.500

2.  Crystal structure of bacterial multidrug efflux transporter AcrB.

Authors:  Satoshi Murakami; Ryosuke Nakashima; Eiki Yamashita; Akihito Yamaguchi
Journal:  Nature       Date:  2002-10-10       Impact factor: 49.962

3.  AcrA, AcrB, and TolC of Escherichia coli Form a Stable Intermembrane Multidrug Efflux Complex.

Authors:  Elena B Tikhonova; Helen I Zgurskaya
Journal:  J Biol Chem       Date:  2004-05-20       Impact factor: 5.157

4.  Interactions underlying assembly of the Escherichia coli AcrAB-TolC multidrug efflux system.

Authors:  Thierry Touzé; Jeyanthy Eswaran; Evert Bokma; Eva Koronakis; Colin Hughes; Vassilis Koronakis
Journal:  Mol Microbiol       Date:  2004-07       Impact factor: 3.501

5.  Genetic evidence for functional interactions between TolC and AcrA proteins of a major antibiotic efflux pump of Escherichia coli.

Authors:  Henri Gerken; Rajeev Misra
Journal:  Mol Microbiol       Date:  2004-11       Impact factor: 3.501

6.  Crystal structure of the drug discharge outer membrane protein, OprM, of Pseudomonas aeruginosa: dual modes of membrane anchoring and occluded cavity end.

Authors:  Hiroyuki Akama; Misa Kanemaki; Masato Yoshimura; Tomitake Tsukihara; Tomoe Kashiwagi; Hiroshi Yoneyama; Shin-ichiro Narita; Atsushi Nakagawa; Taiji Nakae
Journal:  J Biol Chem       Date:  2004-10-26       Impact factor: 5.157

7.  Expression of Pseudomonas aeruginosa multidrug efflux pumps MexA-MexB-OprM and MexC-MexD-OprJ in a multidrug-sensitive Escherichia coli strain.

Authors:  R Srikumar; T Kon; N Gotoh; K Poole
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

8.  Role of the membrane fusion protein in the assembly of resistance-nodulation-cell division multidrug efflux pump in Pseudomonas aeruginosa.

Authors:  Vladislav V Mokhonov; Ekaterina I Mokhonova; Hiroyuki Akama; Taiji Nakae
Journal:  Biochem Biophys Res Commun       Date:  2004-09-17       Impact factor: 3.575

9.  Chimeric analysis of AcrA function reveals the importance of its C-terminal domain in its interaction with the AcrB multidrug efflux pump.

Authors:  Christopher A Elkins; Hiroshi Nikaido
Journal:  J Bacteriol       Date:  2003-09       Impact factor: 3.490

10.  Contribution of outer membrane efflux protein OprM to antibiotic resistance in Pseudomonas aeruginosa independent of MexAB.

Authors:  Q Zhao; X Z Li; R Srikumar; K Poole
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

View more
  8 in total

Review 1.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

2.  Reviving Antibiotics: Efflux Pump Inhibitors That Interact with AcrA, a Membrane Fusion Protein of the AcrAB-TolC Multidrug Efflux Pump.

Authors:  Narges Abdali; Jerry M Parks; Keith M Haynes; Julie L Chaney; Adam T Green; David Wolloscheck; John K Walker; Valentin V Rybenkov; Jerome Baudry; Jeremy C Smith; Helen I Zgurskaya
Journal:  ACS Infect Dis       Date:  2016-11-02       Impact factor: 5.084

Review 3.  Assembly and transport mechanism of tripartite drug efflux systems.

Authors:  Rajeev Misra; Vassiliy N Bavro
Journal:  Biochim Biophys Acta       Date:  2009-03-13

Review 4.  Structure, function, and evolution of bacterial ATP-binding cassette systems.

Authors:  Amy L Davidson; Elie Dassa; Cedric Orelle; Jue Chen
Journal:  Microbiol Mol Biol Rev       Date:  2008-06       Impact factor: 11.056

5.  Assembly of the MexAB-OprM multidrug pump of Pseudomonas aeruginosa: component interactions defined by the study of pump mutant suppressors.

Authors:  Dominic Nehme; Keith Poole
Journal:  J Bacteriol       Date:  2007-06-22       Impact factor: 3.490

6.  Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Authors:  Lucie Vettoretti; Patrick Plésiat; Cédric Muller; Farid El Garch; Gilles Phan; Inna Attrée; Arnaud Ducruix; Catherine Llanes
Journal:  Antimicrob Agents Chemother       Date:  2009-03-02       Impact factor: 5.191

7.  Molecular rationale for the impairment of the MexAB-OprM efflux pump by a single mutation in MexA.

Authors:  Pierpaolo Cacciotto; Andrea Basciu; Francesco Oliva; Giuliano Malloci; Martin Zacharias; Paolo Ruggerone; Attilio V Vargiu
Journal:  Comput Struct Biotechnol J       Date:  2021-12-03       Impact factor: 7.271

Review 8.  Multidrug Resistance (MDR) and Collateral Sensitivity in Bacteria, with Special Attention to Genetic and Evolutionary Aspects and to the Perspectives of Antimicrobial Peptides-A Review.

Authors:  András Fodor; Birhan Addisie Abate; Péter Deák; László Fodor; Ervin Gyenge; Michael G Klein; Zsuzsanna Koncz; Josephat Muvevi; László Ötvös; Gyöngyi Székely; Dávid Vozik; László Makrai
Journal:  Pathogens       Date:  2020-06-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.